美容扮靚 今日: 36|主題: 136617

Saxenda (Liraglutide) belongs to the class of medications called human glucagon-like peptides. It is used for chronic (long-term) management of body weight, together with reduced caloric intake and increased physical activity. It may be prescribed for individuals with a body mass index (BMI) of 30 kg/m² or more, or people with a BMI of 27 kg/m² who also have another weight-related illness, such as high blood pressure, type 2 diabetes or dyslipidemia (high cholesterol).

Liraglutide aids in weight control by affecting sensations of hunger, causing a decrease in appetite and food intake. It slows down the passage of food from the stomach into the intestine, causing the user to “feel full” for longer after a meal. It also decreases the maximum glucose level in the blood and the amount of insulin needed for the body to use the glucose.